When did CorMedix report Q2 2025 earnings?

CorMedix (CRMD) reported Q2 2025 earnings on August 7, 2025 before market open.

What were CorMedix's Q2 2025 revenue and EPS?

CorMedix reported revenue of $39.7M and diluted EPS of $0.28 for Q2 2025.

Did CorMedix beat estimates in Q2 2025?

Revenue missed the consensus estimate of $42.5M by $2.7M. EPS beat the consensus estimate of $0.20 by $0.08.

How did CorMedix's Q2 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 4829.4% from $806.1K a year earlier.

Where can I find CorMedix's Q2 2025 SEC filings?

You can read the 10-Q periodic report (0001213900-25-072843) directly on SEC EDGAR. The filing index links above go to sec.gov.

CorMedix CRMD Q2 2025 earnings

Reported August 7, 2025 · Before market open

Revenue$39.7MMiss by $2.7M Diluted EPS$0.28Beat by $0.08

Revenue estimate$42.5M

EPS estimate$0.20

Next report

Aug 6, 2026 (In 3 weeks)

Revenue estimate$96.0M

EPS estimate$0.26

Financials

Q2 2025

Income statement

See full

Revenue$39.7M+4,829%

Gross profit$37.9M+12,683%

Operating income$19.5M+228%

Net income$19.8M+240%

EPS (diluted)$0.28+212%

Balance sheet

See full

Cash & equivalents$159.4M+457%

Total debt$435.0K-26.8%

Total equity$220.6M+378%

Total assets$252.6M+338%

Cash flow

See full

Operating cash flow$30.0M+314%

CapEx$24.1K-30.7%

Free cash flow$30.0M+313%

Valuation & ratios

Valuation

as of 06/30/25

See full

Market cap$1.07B+348%

Enterprise value$907.22M+332%

P/S8.8×—

Profitability

See full

Gross margin95.7%—

FCF margin25%—

Returns & leverage

See full

Debt / equity0×0.0×

Current ratio7.8×+3.0×

Segments

By product

See full

Contract revenue-—

Versus estimates

Revenue

Q1 2026$127.4MBeat by $22.4M Q4 2025$128.6MBeat by $1.6M Q3 2025$104.3MMiss by $22.7M

Q2 2025$39.7MMiss by $2.7M

Q1 2025$39.1MBeat by $9.2M Q4 2024$31.2MMiss by $58.1K

Diluted EPS

Q1 2026$0.43Beat by $0.08 Q4 2025$0.61Miss by $0.25 Q3 2025$0.57Beat by $0.09

Q2 2025$0.28Beat by $0.08

Q1 2025$0.30Beat by $0.05 Q4 2024$0.22Beat by $0.05

Ask the moment CorMedix reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did CorMedix report Q2 2025 earnings?: CorMedix (CRMD) reported Q2 2025 earnings on August 7, 2025 before market open.
What were CorMedix's Q2 2025 revenue and EPS?: CorMedix reported revenue of $39.7M and diluted EPS of $0.28 for Q2 2025.
Did CorMedix beat estimates in Q2 2025?: Revenue missed the consensus estimate of $42.5M by $2.7M. EPS beat the consensus estimate of $0.20 by $0.08.
How did CorMedix's Q2 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 4829.4% from $806.1K a year earlier.
Where can I find CorMedix's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0001213900-25-072843) directly on SEC EDGAR. The filing index links above go to sec.gov.